410 related articles for article (PubMed ID: 27462068)
21. Temporal patterns of lipid testing and statin therapy in acute coronary syndrome patients (from the Canadian GRACE Experience).
Elbarouni B; Banihashemi SB; Yan RT; Welsh RC; Kornder JM; Wong GC; Anderson FA; Spencer FA; Grondin FR; Goodman SG; Yan AT;
Am J Cardiol; 2012 May; 109(10):1418-24. PubMed ID: 22381155
[TBL] [Abstract][Full Text] [Related]
22. Effects of statins on plaque rupture assessed by optical coherence tomography in patients presenting with acute coronary syndromes: insights from the optical coherence tomography (OCT)-FORMIDABLE registry.
Gili S; Iannaccone M; Colombo F; Montefusco A; Amabile N; Calcagno S; Capodanno D; Scalone G; Rognoni A; Omedè P; Ugo F; Cavallo E; Mancone M; Mangiameli A; Boccuzzi G; Hiansen J; Motreff P; Toutouzas K; Garbo R; Sardella G; Tamburino C; D'Amico M; Moretti C; Templin C; Gaita F; Souteyrand G; Niccoli G; D'Ascenzo F
Eur Heart J Cardiovasc Imaging; 2018 May; 19(5):524-531. PubMed ID: 28605473
[TBL] [Abstract][Full Text] [Related]
23. Impact of ezetimibe coadministered with statins on cardiovascular events following acute coronary syndrome: a 3-year population-based retrospective cohort study in Taiwan.
Lin CF; Gau CS; Wu FL; Hsiao FY; Bai CH; Shen LJ
Clin Ther; 2011 Sep; 33(9):1120-31. PubMed ID: 21872930
[TBL] [Abstract][Full Text] [Related]
24. Statins in Familial Hypercholesterolemia: Consequences for Coronary Artery Disease and All-Cause Mortality.
Besseling J; Hovingh GK; Huijgen R; Kastelein JJP; Hutten BA
J Am Coll Cardiol; 2016 Jul; 68(3):252-260. PubMed ID: 27417002
[TBL] [Abstract][Full Text] [Related]
25. Impact of prior statin therapy on arrhythmic events in patients with acute coronary syndromes (from the Global Registry of Acute Coronary Events [GRACE]).
Vedre A; Gurm HS; Froehlich JB; Kline-Rogers E; Montalescot G; Gore JM; Brieger D; Quill AL; Eagle KA;
Am J Cardiol; 2009 Dec; 104(12):1613-7. PubMed ID: 19962463
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness of a combination of ezetimibe and statins in patients with acute coronary syndrome and multiple comorbidities: A 6-year population-based cohort study.
Lin Wu FL; Wang J; Ho W; Chou CH; Wu YJ; Choo DW; Wang YW; Chen PY; Chien KL; Lin ZF
Int J Cardiol; 2017 Apr; 233():43-51. PubMed ID: 28190615
[TBL] [Abstract][Full Text] [Related]
27. Comparison of characteristics, management practices, and outcomes of patients between the global registry and the gulf registry of acute coronary events.
Awad HH; Zubaid M; Alsheikh-Ali AA; Al Suwaidi J; Anderson FA; Gore JM; Goldberg RJ
Am J Cardiol; 2011 Nov; 108(9):1252-8. PubMed ID: 21880292
[TBL] [Abstract][Full Text] [Related]
28. Diabetes mellitus and cardiovascular events in older patients with myocardial infarction prescribed intensive-dose and moderate-dose statins.
Ko DT; Wijeysundera HC; Jackevicius CA; Yousef A; Wang J; Tu JV
Circ Cardiovasc Qual Outcomes; 2013 May; 6(3):315-22. PubMed ID: 23674307
[TBL] [Abstract][Full Text] [Related]
29. Usefulness of Elevated Levels of Growth Differentiation Factor-15 to Classify Patients With Acute Coronary Syndrome Having Percutaneous Coronary Intervention Who Would Benefit from High-Dose Statin Therapy.
Tentzeris I; Farhan S; Freynhofer MK; Rohla M; Jarai R; Vogel B; Baumgartner-Parzer S; Nürnberg M; Geppert A; Wessely E; Wojta J; Huber K; Kautzky-Willer A
Am J Cardiol; 2017 Sep; 120(5):747-752. PubMed ID: 28734463
[TBL] [Abstract][Full Text] [Related]
30. Association of Discharge Aspirin Dose With Outcomes After Acute Myocardial Infarction: Insights From the Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome (TRANSLATE-ACS) Study.
Xian Y; Wang TY; McCoy LA; Effron MB; Henry TD; Bach RG; Zettler ME; Baker BA; Fonarow GC; Peterson ED
Circulation; 2015 Jul; 132(3):174-81. PubMed ID: 25995313
[TBL] [Abstract][Full Text] [Related]
31. Statin Utilization Patterns and Outcomes for Patients with Acute Coronary Syndrome During and Following Inpatient Admissions.
Boklage SH; Malangone-Monaco E; Lopez-Gonzalez L; Ding Y; Henriques C; Elassal J
Cardiovasc Drugs Ther; 2018 Jun; 32(3):273-280. PubMed ID: 29855748
[TBL] [Abstract][Full Text] [Related]
32. Association between statin treatment and LDL-cholesterol levels on the rate of ST-elevation myocardial infarction among patients with acute coronary syndromes: ACS Israeli Survey (ACSIS) 2002-2010.
Gottlieb S; Kolker S; Shlomo N; Matetzky S; Leitersdorf E; Segev A; Goldenberg I; Tzivoni D; Weisz G; Moriel M
Int J Cardiol; 2016 May; 210():133-8. PubMed ID: 26945433
[TBL] [Abstract][Full Text] [Related]
33. Familial hypercholesterolemia related admission for acute coronary syndrome in the United States: Incidence, predictors, and outcomes.
Kheiri B; Simpson TF; Osman M; Balla S; Rahmouni H; Mehta A; Pokharel Y; Nasir K; Fazio S; Shapiro MD
J Clin Lipidol; 2021; 15(3):460-465. PubMed ID: 34053910
[TBL] [Abstract][Full Text] [Related]
34. Real-life effectiveness of statins in the prevention of first acute coronary syndrome in France: a prospective observational study.
Grimaldi-Bensouda L; Rossignol M; Danchin N; Dallongeville J; Bruckert E; Banayan J; Cottin Y; Aubrun E; Khachatryan A; Bénichou J; Abenhaim L;
Int J Cardiol; 2013 Nov; 169(4):271-5. PubMed ID: 24090749
[TBL] [Abstract][Full Text] [Related]
35. GRACE score predicts heart failure admission following acute coronary syndrome.
McAllister DA; Halbesma N; Carruthers K; Denvir M; Fox KA
Eur Heart J Acute Cardiovasc Care; 2015 Apr; 4(2):165-71. PubMed ID: 24986419
[TBL] [Abstract][Full Text] [Related]
36. Antiatherosclerotic effects of long-term maximally intensive statin therapy after acute coronary syndrome: insights from Study of Coronary Atheroma by Intravascular Ultrasound: Effect of Rosuvastatin Versus Atorvastatin.
Puri R; Nissen SE; Shao M; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; Uno K; Kataoka Y; Nicholls SJ
Arterioscler Thromb Vasc Biol; 2014 Nov; 34(11):2465-72. PubMed ID: 25212234
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular disease and mortality in statin-treated patients with familial hypercholesterolemia.
Mohrschladt MF; Westendorp RG; Gevers Leuven JA; Smelt AH
Atherosclerosis; 2004 Feb; 172(2):329-35. PubMed ID: 15019543
[TBL] [Abstract][Full Text] [Related]
38. Statins do not increase the risk of developing type 2 diabetes in familial hypercholesterolemia: The SAFEHEART study.
Fuentes F; Alcala-Diaz JF; Watts GF; Alonso R; Muñiz O; Díaz-Díaz JL; Mata N; Sanchez Muñoz-Torrero JF; Brea Á; Galiana J; Figueras R; Aguado R; Piedecausa M; Cepeda JM; Vidal JI; Rodríguez-Cantalejo F; López-Miranda J; Mata P;
Int J Cardiol; 2015 Dec; 201():79-84. PubMed ID: 26296047
[TBL] [Abstract][Full Text] [Related]
39. Recurrent ischemia across the spectrum of acute coronary syndromes: prevalence and prognostic significance of (re-)infarction and ST-segment changes in a large contemporary registry.
Yan AT; Steg PG; Fitzgerald G; Feldman LJ; Eagle KA; Gore JM; Anderson FA; López-Sendón J; Gurfinkel EP; Brieger D; Goodman SG;
Int J Cardiol; 2010 Nov; 145(1):15-20. PubMed ID: 19481280
[TBL] [Abstract][Full Text] [Related]
40. Coronary heart disease mortality in treated familial hypercholesterolaemia: Update of the UK Simon Broome FH register.
Humphries SE; Cooper JA; Seed M; Capps N; Durrington PN; Jones B; McDowell IFW; Soran H; Neil HAW;
Atherosclerosis; 2018 Jul; 274():41-46. PubMed ID: 29751283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
